Home > Investors
Investor Relations Home
E-mail Page Print Page RSS Feeds E-mail Alerts IR Contacts Financial Tear Sheet 
About Us
Download Documentation 2016 Guidance Worksheet
Download Documentation ALN-PCSsc Phase 1 Clinical Results Presentation
Download Documentation Update on ABP-700
Download Documentation ALN-PCSsc Phase 1 Clinical Results Presentation
Download Documentation ABP-700 & MDCO-216 Conference Call Presentation
Corporate Profile
The Medicines Company provides medical solutions to improve health outcomes for patients in acute and intensive care hospitals worldwide. These solutions comprise medicines and knowledge that directly impact the survival and well-being of critically ill patients.
Stock Quote
MDCO (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$29.45
Change (%) Stock is Down 0.63 (2.09%)
Volume529,811
Data as of 04/20/18 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent News
DateTitle 
04/19/18The Medicines Company to Announce First-Quarter 2018 Financial Results on April 25
PARSIPPANY, N.J.--(BUSINESS WIRE)--Apr. 19, 2018-- The Medicines Company (NASDAQ:MDCO) will host a conference call and audio webcast on Wednesday, April 25, 2018, at 8:30 a.m., Eastern Time, to discuss first-quarter 2018 financial results and operational developments. The conference call may be accessed by telephone as follows: U.S./Canada:     ... 
Printer Friendly Version
03/27/18The Medicines Company Announces Chief Financial Officer Transition
PARSIPPANY, N.J.--(BUSINESS WIRE)--Mar. 27, 2018-- The Medicines Company (NASDAQ: MDCO) today announced the appointment of Christopher Visioli as Chief Financial Officer and Treasurer of the Company, effective immediately. Mr. Visioli succeeds William B. O’Connor, who is retiring from the Company after serving as Chief Accounting Officer and then Chief Financial Officer for a total of 13 years. Mr. O’Connor will remain with the Company as an advisor thro... 
Printer Friendly Version
03/16/18The Medicines Company to Participate in the Oppenheimer 28th Annual Healthcare Conference
PARSIPPANY, N.J.--(BUSINESS WIRE)--Mar. 16, 2018-- The Medicines Company (NASDAQ:MDCO) today announced that it will participate in the Oppenheimer 28th Annual Healthcare Conference on Tuesday, March 20, 2018, in New York City, NY. The Company is scheduled to present at 08:00 a.m., Eastern Time. A live audio webcast will be available in the “Investors-Events/Presentations” section of The Medicines Company website. A replay of the presentati... 
Printer Friendly Version
03/08/18The Medicines Company Reaches Enrollment Target for ORION-10 Ahead of Schedule
ORION-10, a Phase III pivotal clinical trial conducted in the United States completed randomization of more than 1,500 patients in 12 weeks – 10 weeks ahead of schedule All pivotal LDL-C lowering trials with 18 months follow up (ORION-9, ORION-10 and ORION-11) have now completed enrollment with data read-out expected in Q3/2019 PARSIPPANY, N.J.--(BUSINESS WIRE)--Mar. 8, 2018-- The Medicines Company (NA... 
Printer Friendly Version
Upcoming Events
DateTitle
04/25/18 8:30 a.m. ET
Q1 2018 The Medicines Company Earnings Conference Call

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.